Tests · Tumor marker panel

A blood draw.
Read alongside your imaging, not instead of it.

A tumor marker panel is a blood test measuring proteins that can be elevated in certain cancers, used as a supporting data point alongside imaging rather than a stand-alone diagnostic test. One draw covers the standard panel.

Price my program How it works
5 min
Draw time

A single blood draw.

0 mSv
Radiation dose

A laboratory test, not imaging.

₩450,000
Cheapest program including them

Hanaro's Basic program, men's price, which lists AFP, CEA and PSA, with CA-125 for women. Every entry program across the three centres includes a marker panel.

₩500,000
The other two entry programs

KMI Global's Standard and MediOne's Basic, both of which include tumour markers in their blood panel at the same price.

From 1 wk
Earliest slot

One week is the earliest an imaging slot can be held, and there is no referral step before it. Meridiko's own operating figure.

~1 wk
Full written report

English report in your hands, which is Meridiko's own delivery target rather than a centre's published figure. You get a consultation on preliminary findings on the day of the screening, before you leave.

Programme contents and prices from each partner centre's own foreigner-facing published list, read 2026-08-05: KMI Global, Hanaro Medical Foundation's English site and MediOne's English site. Standalone per-test prices are MediOne's 비급여 (non-covered) posting, the itemised list 의료법 제45조 requires a clinic to publish, read the same day. Report turnaround is Meridiko's own delivery target rather than a centre's published figure, and is labelled as ours where it appears (https://global.kmi.or.kr/examination/foreigner_examination; https://en-mobile.hanaromf.com/program/prog01/prog01_01.jsp; https://en.medionemedicalcenter.com/m1; https://medionemedicalcenter.com/115), measured 2026-08-05.

What it finds, and what it does not

What it finds, and what it does not.

Elevated levels of specific proteins associated with certain cancers, useful as a supporting signal alongside imaging and clinical history.

Tumor markers are neither sensitive nor specific enough to diagnose or exclude cancer on their own. A normal result does not rule out cancer, and an elevated one is not itself a diagnosis; both need to be read with your imaging and your own doctor.

Suitability

Who it suits, and who should not have it.

Suits: Anyone undergoing a comprehensive screening who wants this data point recorded alongside their imaging results.

Should not have it: Anyone expecting a stand-alone answer from this test alone. It is not designed to be read that way, and no reputable clinic should present it as one.

In context

How it differs from the related test.

Imaging (whole-body MRI, low-dose chest CT) looks for structural findings directly; a tumor marker panel is a blood chemistry signal that supports, but does not replace, imaging.

Which tier includes it

Included from Essential.

Included in every Meridiko tier, starting at Essential. See /pricing/ for the full tier ladder.

SEE THE FULL TIER LADDER
Related tests

Often booked together.

Full blood panel

The baseline every program includes. Because the scans need context.

Colonoscopy

The test with a three-day wait. Not a three-month one.
FAQ

Questions worth asking before you book.

Can a tumor marker test diagnose cancer?
No. It is a supporting data point, not a diagnostic test on its own. Elevated markers can have non-cancer causes, and many early cancers do not raise markers at all.
What happens if a marker is elevated?
Your report flags it alongside your imaging results; your own doctor decides what, if anything, warrants further investigation.
Do I need to fast before this blood draw?
Typically not for the tumor marker panel specifically, but if it is drawn alongside other bloods that do require fasting, your coordinator sends combined instructions.

© 2026 Meridiko